medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2021, Number 08

<< Back

Ginecol Obstet Mex 2021; 89 (08)

Gonorrhoeae and pregnancy: related to two cases

Martínez-Velasco IG, Figueroa-Damián R, Vargas-Martínez G, Flores-Espíndola N, Guillén-González MA

Language: Spanish
References: 37
Page: 662-669
PDF size: 238.10 Kb.


ABSTRACT

Background: We report two rare cases of Gonorrhoeae in women pregnancy located in Bartholin and Skene glands. These infections produced severe complications in woman reproductive health and could transmitted to the newborn at birth.
Clinical cases: First patient; a 19 years old woman on the 27 + 0 week of pregnancy complicated with bartholinitis and labor premature. Microbiologic culture by aspiration show N gonorrhoeae. Second patient: a 24 years old woman on the 34 + 3 week of pregnancy complicated with skeneitis. Microbiologic culture by aspiration show N. gonorrhoeae. Both mothers respond adequally to treatment. Their newborns were asymptomatic.
Conclusiones: N gonorrhoeae infection in the external genital glands of pregnant women is rare. Perhaps because gonorrhea is a reemerging infection it should be considered. Microbiological confirmation is urgent because the prognosis for both mother and child will depend on it and the surgical treatment and strict follow-up of complications in the mother and her child. The above without neglecting the treatment of the couple. It is essential to be updated in the knowledge of this old infectious disease and its treatment in order to be able to apply measures for its control in the near future.


REFERENCES

  1. González-Hernández M, Navarro-Gracia JF, Ros-Vivancos C, Martínez–Vicente M, García-Román V, González-Torga A. La gonococia. Prevención y tratamiento a lo largo de la historia. Rev Esp Med Prev y Sal Pub 2018; 23 (3): 29-36. http://www.sempsph.com/revista/2018/10/pdf/Revistade- Medicina-Preventiva.pdf

  2. García SD, Casco RH, Losada MO, Perazzi BE, et al. Estado actual de la gonorrea. Rev Asoc Med Arg 2016; 129 (2): 6-9. file:///C:/Users/nizjo/AppData/Local/Temp/RevAMA- 2-2016-Pag-6-ArticuloOriginal.pdf

  3. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013; 40 (3): 187-93. doi: 10.1097/ OLQ.0b013e318286bb53

  4. Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med 2012; 366 (6): 485-7. doi: 10.1056/NEJMp1112456

  5. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One 2015; 10 (12): e0143304. doi: 10.1371/journal.pone.0143304

  6. Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 2014; 27 (3): 587-613. doi: 10.1128/CMR.00010-14

  7. García-Mendiola R, Aguilera-Arreola MG, Contreras-Rodríguez A. Neisseria gonorrhoeae. Rev Chilena Infectol 2017; 34 (3): 263-64. doi: 10.4067 / S0716-10182017000300010.

  8. Humbert MV, Christodoulides M. Atypical, Yet Not infrequent, infections with Neisseria Species. Pathogens 2020; 9 (1): 10. doi: 10.3390/pathogens9010010

  9. Moi H, Blee K, Horner PJ. Management of non-gonococcal urethritis. BMC Infect Dis 2015; 15: 294. https://doi. org/10.1186/s12879-015-1043-4

  10. Stevens JS, Criss AK. Pathogenesis of Neisseria gonorrhoeae in the female reproductive tract: neutrophilic host response, sustained infection, and clinical sequelae. Curr Opin Hematol 2018; 25 (1): 13-21. doi: 10.1097/ MOH.0000000000000394.

  11. Densen P. Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae. Clin Microbiol Rev 1989; 2 Suppl (Suppl): S11-7. doi: 10.1128/cmr.2.suppl.s11

  12. Ngampasutadol J, Ram S, Gulati S, Agarwal S, Li C, et al. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J Immunol 2008; 180 (5): 3426-35. doi: 10.4049/ jimmunol.180.5.3426

  13. Shaskolskiy B, Dementieva E, Kandinov I, Filippova M, et al. Resistance of Neisseria gonorrhoeae isolates to betalactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015-2017. PLoS One 2019; 14 (7): e0220339. doi: 10.1371/journal.pone.0220339

  14. Fifer H, Natarajan U, Jones L, Alexander S, Hughes G, Golparian D, Unemo M. Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea. N Engl J Med. 2016; 374 (25): 2504-6. doi: 10.1056/NEJMc1512757

  15. Unemo M. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 2015; 15: 364. doi: 10.1186/s12879-015-1029-2

  16. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 (33): 924.

  17. Eyre DW, Town K, Street T, Barker L, et al. Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018. Euro Surveill 2019; 24 (10): 1900147. doi: 10.2807/1560-7917. ES.2019.24.10.1900147

  18. World Health Organization (WHO), Department of Reproductive Health and Research. Global Action Plan to Control the Spread and Impact Of Antimicrobial Resistance in Neisseria gonorrhoeae. 2012. http://www.who.int/ reproductivehealth/ publications/rtis/9789241503501

  19. Bazzo ML, Golfetto L, Gaspar PC, Pires AF, Ramos MC, et al. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16. J Antimicrob Chemother 2018; 73 (7): 1854-61. doi: 10.1093/jac/ dky090. PMID: 29635367

  20. Berrocal AJ, Barrios MM, Fiestas SV. Resistencia antimicrobiana de Neisseria gonorrhoeae en Perú. Rev Peru Med Exp Salud Pública 2018; 35 (1): 155-6. file:///C:/Users/nizjo/ AppData/Local/Temp/3552-14741-3-PB.pdf

  21. Goggins ER, Kim TG, Young MR, Jamieson DJ, Haddad LB. Patterns of Screening, Infection, and Treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnancy. Obstetrics & Gynecology 2020;135(4): 799-807doi: 10.1097/AOG.000000000

  22. Williams CL, Harrison LL, Llata E, Smith RA, Meites E. Sexually Transmitted Diseases Among Pregnant Women: 5 States, United States, 2009-2011. Matern Child Health J 2018; 22 (4): 538-45. doi: 10.1007/s10995-017-2422-9

  23. Borges-Costa J, Matos C, Pereira F. Sexually transmitted infections in pregnant adolescents: prevalence and association with maternal and foetal morbidity. J Eur Acad Dermatol Venereol 2012; 26 (8): 972-5. doi: 10.1111/j.1468- 3083.2011.04194.x

  24. Bristow CC, Mathelier P, Ocheretina O, Benoit D, Pape JW, Wynn A, Klausner JD. Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis screening and treatment of pregnant women in Port-au- Prince, Haiti. Int J STD AIDS 2017; 28 (11): 1130-34. doi: 10.1177/0956462416689755

  25. Ovalle A, Martínez MA, de la Fuente F, Falcon N, et al. Prevalencia de infecciones de transmisión sexual en mujeres embarazadas atendidas en un hospital público de Chile. Rev Chilena Infectol. 2012; 29: 517-20. http://dx.doi. org/10.4067/S0716- 10182012000600006

  26. Ovalle A, Martínez MA, Ferrand P, Peña V, Schwarze J E. Infección intraamniótica por Neisseria gonorrhoeae en un caso de rotura prematura de membranas de pretérmino. Rev Chil Obstet Ginecol 1999; 64: 73-8.

  27. Hammerschlag MR. Chlamydial and gonococcal infections in infants and children. Clin Infect Dis 2011; 53 (Suppl 3): S99-102. doi: 10.1093/cid/cir699. PMID: 22080275

  28. Alexandre I, Justel M, Martínez P, Ortiz de Lejarazu R, Pastor C. First attempt to implement ophtalmia neonatorum prophilaxis in Angola: Microorganisms, efficacy, and obstacles. Journal of Ophtalmology 2015; 15: 1-6. https:// doi.org/10.1155/2015/326526

  29. Lee YH, Rankin JS, Alpert S, Daly AK, McCormack WM. Microbiological investigation of Bartholin's gland abscesses and cysts. Am J Obstet Gynecol 1977; 129 (2): 150-3. doi: 10.1016/0002-9378(77)90736-0

  30. Tanaka, Kaori y col. Microbiología del absceso de la glándula de Bartholin en Japón. Revista de Microbiología Clínica 2005; 43 (8): 4258-61. doi: 10.1128 / JCM.43.8.4258-4261.2005

  31. Pourabbas B, Rezaei Z, Mardaneh J, Shahian M, Alborzi A. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections among pregnant women and eye colonization of their neonates at birth time, Shiraz, Southern Iran. BMC Infect Dis. 2018 Sep 24;18(1):477. doi: 10.1186/s12879-018-3382-4

  32. Verma R, Sood S. Gonorrhoea diagnostics: An update. Indian J Med Microbiol [serial online] 2016 [cited 2020 Apr 17]; 34:139-45. http://www.ijmm.org/text. asp?2016/34/2/139/180278.

  33. Mullick S, Watson-Jones D, Beksinska M, Mabey D. Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect. 2005 Aug;81(4):294-302. doi: 10.1136/sti.2002.004077

  34. Ng, Lai-King, and Irene E Martin. “The laboratory diagnosis of Neisseria gonorrhoeae.” Can J Infect Dis Med Microbiol 2005; 16 (1): 15-25. doi:10.1155/2005/323082

  35. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep. 2014; 63 (RR-02): 1-19. PMID: 24622331

  36. Edwards JL, Jennings MP, Seib KL. Neisseria gonorrhoeae vaccine development: hope on the horizon? Curr Opin Infect Dis 2018; 31 (3): 246-50. doi: 10.1097/ QCO.0000000000000450

  37. Poole J, Day CJ, Haselhorst T, Jen FE, et al. Repurposed drugs that block the gonococcus-complement receptor 3 interaction can prevent and cure gonococcal infection of primary human cervical epithelial cells. mBio 2020; 11 (2): e03046-19. doi: 10.1128/mBio.03046-19




2020     |     www.medigraphic.com